NEI
RMD icon

Northwest & Ethical Investments’s ResMed RMD Stock Holding History

Northwest & Ethical Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
8,677
-6,873
-44% -$1.42M 0.04% 235
2026
Q1 		$3.49M Buy
15,550
+2,333
+18% +$581K 0.08% 206
2025
Q4 		$3.18M Buy
13,217
+573
+5% +$147K 0.07% 229
2025
Q3 		$3.46M Hold
12,644
– – 0.08% 216
2025
Q2 		$3.26M Sell
12,644
-6,133
-33% -$1.46M 0.08% 213
2025
Q1 		$4.2M Buy
18,777
+5,551
+42% +$1.3M 0.11% 195
2024
Q4 		$3.02M Buy
+13,226
New +$3.18M 0.08% 220
2019
Q2 		– Sell
-17,360
Closed -$1.8M – 380
2019
Q1 		$1.8M Buy
17,360
+10,260
+145% +$1.06M 0.09% 269
2018
Q4 		$808K Buy
7,100
+2,100
+42% +$225K 0.05% 324
2018
Q3 		$577K Buy
+5,000
New +$548K 0.04% 316
2017
Q3 		– Sell
-1,025
Closed -$79.8K – 370
2017
Q2 		$79.8K Buy
1,025
+100
+11% +$7.16K 0.01% 353
2017
Q1 		$66.6K Hold
925
– – ﹤0.01% 371
2016
Q4 		$57.4K Buy
+925
New +$56.7K ﹤0.01% 373

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northwest & Ethical Investments's RMD Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its ResMed (RMD) stake by 44% in Q2 2026, selling an estimated $1.42M and leaving 8,677 shares worth $1.69M. The position accounts for 0.04% of the portfolio, ranked #235.

Northwest & Ethical Investments first reported a position in RMD in Q4 2016 and has held it in 13 quarters since. The position peaked at $4.2M in Q1 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Northwest & Ethical Investments held 8,677 shares of ResMed worth $1.69M as of Q2 2026.
  • Northwest & Ethical Investments sold 6,873 ResMed shares in Q2 2026, an estimated $1.42M.
  • ResMed made up 0.04% of Northwest & Ethical Investments's portfolio in Q2 2026, its #235 holding.
  • Northwest & Ethical Investments first reported a position in ResMed in Q4 2016 and has held it in 13 quarters since.
  • Northwest & Ethical Investments's ResMed position peaked at $4.2M in Q1 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.